tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Leboyer, 4 are a BUY (100%).
Analyst Robert Leboyer works at NOBLE CAPITAL with a stock forecast success ratio of 100% fulfilled within 430 days on average.
Robert Leboyer’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TNXP, Tonix Pharmaceuticals Holding Corp at 24-May-2022.
Analyst best performing recommendations are on TNXP (TONIX PHARMACEUTICALS HOLDING CORP).
The best stock recommendation documented was for TNXP (TONIX PHARMACEUTICALS HOLDING CORP) at 4/18/2022. The price target of $19.2 was fulfilled within 28 days with a profit of $15.56 (44.76%) receiving and performance score of 15.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 2 months 13 days ago
0/1 (0%)
$242.25 (224.83%)
Hold
6
$5.15 (605.88%)
1 years 4 months 14 days ago
1/1 (100%)
$-4.98 (-45.36%)
1
Buy
5
$4.11 (461.80%)
1 years 5 months 27 days ago
0/1 (0%)
$3.97 (385.44%)
Buy
7
$-0.86 (-10.94%)
12
1 years 5 months 27 days ago
2/2 (100%)
$-25.13 (-72.62%)
132
Buy
1 years 8 months 26 days ago
2/2 (100%)
$-67.63 (-75.69%)
945
What Year was the first public recommendation made by Robert Leboyer?
